Merchant MS - Search Results

1

Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.

Majzner RG, Simon JS, Grosso JF, Martinez D, Pawel BR, Santi M, Merchant MS, Geoerger B, Hezam I, Marty V, Vielh P, Daugaard M, Sorensen PH, Mackall CL, Maris JM. Majzner RG, et al. Among authors: merchant ms. Cancer. 2017 Oct 1;123(19):3807-3815. doi: 10.1002/cncr.30724. Epub 2017 Jun 13. Cancer. 2017. PMID: 28608950 Free article.

2

Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.

Merchant MS, Woo CW, Mackall CL, Thiele CJ. Merchant MS, et al. J Natl Cancer Inst. 2002 Nov 20;94(22):1673-9. doi: 10.1093/jnci/94.22.1673. J Natl Cancer Inst. 2002. PMID: 12441322

3

Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.

Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ. Yang X, et al. Among authors: merchant ms. Cancer Res. 2003 Mar 1;63(5):1122-9. Cancer Res. 2003. PMID: 12615731

4

Tumor expression of 4-1BB ligand sustains tumor lytic T cells.

Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Zhang H, et al. Among authors: merchant ms. Cancer Biol Ther. 2003 Sep-Oct;2(5):579-86. doi: 10.4161/cbt.2.5.545. Cancer Biol Ther. 2003. PMID: 14614331

5

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.

Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ. Beppu K, et al. Among authors: merchant ms. J Natl Cancer Inst. 2004 Jan 7;96(1):46-55. doi: 10.1093/jnci/djh004. J Natl Cancer Inst. 2004. PMID: 14709738

6

Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma.

Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL. Merchant MS, et al. Cancer Res. 2004 Nov 15;64(22):8349-56. doi: 10.1158/0008-5472.CAN-04-1705. Cancer Res. 2004. PMID: 15548704

7

Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.

Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL. Merchant MS, et al. Cancer Immunol Immunother. 2007 Jul;56(7):1037-46. doi: 10.1007/s00262-006-0257-0. Epub 2006 Dec 6. Cancer Immunol Immunother. 2007. PMID: 17149595 Free PMC article.

8

Current approach to pediatric soft tissue sarcomas.

Merchant MS, Mackall CL. Merchant MS, et al. Oncologist. 2009 Nov;14(11):1139-53. doi: 10.1634/theoncologist.2009-0160. Epub 2009 Nov 6. Oncologist. 2009. PMID: 19897537 Free article. Review.

9

Immune-based therapies for childhood cancer.

Mackall CL, Merchant MS, Fry TJ. Mackall CL, et al. Among authors: merchant ms. Nat Rev Clin Oncol. 2014 Dec;11(12):693-703. doi: 10.1038/nrclinonc.2014.177. Epub 2014 Oct 28. Nat Rev Clin Oncol. 2014. PMID: 25348789 Free PMC article. Review.

10

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.

Merchant MS, Bernstein D, Amoako M, Baird K, Fleisher TA, Morre M, Steinberg SM, Sabatino M, Stroncek DF, Venkatasan AM, Wood BJ, Wright M, Zhang H, Mackall CL. Merchant MS, et al. Clin Cancer Res. 2016 Jul 1;22(13):3182-91. doi: 10.1158/1078-0432.CCR-15-2550. Epub 2016 Jan 28. Clin Cancer Res. 2016. PMID: 26823601 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page